GGrantIndex
← Leaderboards

Anthony D Elias

Dana-Farber Cancer Institute

$10,988,390
Attributed
$10,988,390
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $882.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,988,390 · 6

By mechanism

U10$5,604,742 · 2
UG1$4,482,247 · 1
P30$755,991 · 2
R21$145,410 · 1

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Others in their field

Top investigators on “Cancer Center

Research focus

Cancer CenterClinical TrialsColoradoThe University Of Colorado Cancer CenterGrantUniversitiesMonitorResearch PersonnelBaseLeadershipSiteSouthwest Oncology GroupMalignant NeoplasmsHospitalsCancer Center Support GrantComprehensive Cancer CenterMemberWyomingResearch SupportPublicationsModalityClinical ResearchClinical CareCaring

Grant awards (36)

NCI National Clinical Trials Network - Lead Academic Participant Sites$618,036
UG1 · FY2025 · CA · contact PI
NCI National Clinical Trials Network - Lead Academic Participant Sites$618,036
UG1 · FY2024 · CA · contact PI
NCI National Clinical Trials Network - Lead Academic Participant Sites$650,564
UG1 · FY2023 · CA · contact PI
NCI National Clinical Trials Network - Lead Academic Participant Sites$650,564
UG1 · FY2022 · CA · contact PI
NCI National Clinical Trials Network - Lead Academic Participant Sites$650,564
UG1 · FY2021 · CA · contact PI
NCI National Clinical Trials Network - Lead Academic Participant Sites$650,564
UG1 · FY2020 · CA · contact PI
NCI National Clinical Trials Network - Lead Academic Participant Sites$643,919
UG1 · FY2019 · CA · contact PI
University of Colorado NTCN Lead Academic Participating Site (LAPS)$768,950
U10 · FY2018 · CA · contact PI
University of Colorado NTCN Lead Academic Participating Site (LAPS)$768,950
U10 · FY2017 · CA · contact PI
University of Colorado NTCN Lead Academic Participating Site (LAPS)$768,950
U10 · FY2016 · CA · contact PI
DATA SHARING$113,871
P30 · FY2016 · CA · contact PI
University of Colorado NTCN Lead Academic Participating Site (LAPS)$692,055
U10 · FY2015 · CA · contact PI
DATA SHARING$114,165
P30 · FY2015 · CA · contact PI
University of Colorado NTCN Lead Academic Participating Site (LAPS)$768,950
U10 · FY2014 · CA · contact PI
DATA SHARING$110,066
P30 · FY2014 · CA · contact PI
DATA SHARING$121,155
P30 · FY2013 · CA · contact PI
University of Colorado Southwest Oncology Group$65,962
U10 · FY2013 · CA · contact PI
DATA SHARING$961
P30 · FY2013 · CA · contact PI
DATA SHARING$114,117
P30 · FY2012 · CA · contact PI
University of Colorado Southwest Oncology Group$1
U10 · FY2012 · CA · contact PI
University of Colorado Southwest Oncology Group$231,603
U10 · FY2010 · CA · contact PI
DATA SHARING$39,860
P30 · FY2010 · CA · contact PI
University of Colorado Southwest Oncology Group$83,653
U10 · FY2009 · CA · contact PI
DATA SHARING$42,169
P30 · FY2009 · CA · contact PI
University of Colorado Southwest Oncology Group$420,576
U10 · FY2008 · CA · contact PI
University of Colorado Southwest Oncology Group$82,101
U10 · FY2008 · CA · contact PI
DATA SHARING$39,657
P30 · FY2008 · CA · contact PI
University of Colorado Southwest Oncology Group$356,613
U10 · FY2007 · CA · contact PI
University of Colorado Southwest Oncology Group$82,102
U10 · FY2007 · CA · contact PI
DATA SHARING$38,574
P30 · FY2007 · CA · contact PI
University of Colorado Southwest Oncology Group$164,202
U10 · FY2006 · CA · contact PI
DATA SHARING$21,396
P30 · FY2006 · CA · contact PI
University of Colorado Southwest Oncology Group$169,280
U10 · FY2005 · CA
University of Colorado Southwest Oncology Group$129,969
U10 · FY2004 · CA
UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP$50,825
U10 · FY2004 · CA
MINIMAL RESIDUAL TUMOR IN SMALL CELL LUNG CANCER$145,410
R21 · FY2000 · CA